(ADPnews) - Jan 26, 2011 - Several brokers have reviewed their stance on Danish medical supplies company Coloplast A/S (CPH: COLO B), which yesterday posted its financial results for the first quarter of fiscal 2010/11, started October 1.
Danske Markets Equities has cut its rating on Coloplast to "hold" from "accumulate" and Carnegie -- to "neutral" from "outperform". The brokers have kept their share price targets at DKK 850 and DKK 840, respectively.
There are also several brokers that have maintained their ratings on the stock. According to Jyske Bank, Coloplast's report, which was released a day earlier than expected, did not offer any big surprises so the broker …
No comments:
Post a Comment